26.06.20 ijBio Portfolio

Pharm Involved.

$1,000,000 on 12.06.20 Changes for 26.06.20:

AstraZeneca (AZN) $51,3 $52,7 (+2.7%) $102,700

Inovio (INO) $13,2 $30 (+127,3%) $227,300

Moderna (MRNA)$61,5 $61,3 (-0.3%) $99,700

Abbot (ABT) $88,5 $88,7 (+0.2%) $100,200

Gilead (GILD) $72,5 $74,6 (+2.9%) $102,900

Adaptive (ADPT) $42,2 $46,3 (+9.7%) $109,700

CytoDyn (CYDY) $3,12 $6,93 (+122.1%) $222,100

AbbVie (ABBV) $92,2 $96,1 (+4.2%) $104,200

Arcus (RCUS) $27,3 $22,7 (-16,8%) $83,200

Sorrento (SRNE) $4,6 $5,87 (+27,6%) $127,600

At close 26.06.20= $1,279,600 (-1,1%)

per million dollars at 10% per share.

previous day

At close 25.06.20= $1,294,100 (+10,3%)

At close 24.06.20= $1,172,600 (+3%)

-

At close 19.06.20= $1,057,700

during the week 12-19.06 +3%

12.06.20 = $1,000,000

Global Communication Platforms portfoilio

--

Portfolio News:

How Gilead’s CEO Moved Aggressively to Test and Distribute Remdesivir

After Building a Cancer-Drug Franchise, Merck’s CEO Is Now Tackling Covid-19

How to Position Your Portfolio for a Joe Biden Presidency

GlaxoSmithKline (GSK) Stock Moves -1.39%: What You Should Know

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Sorrento Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 27, 2020 - SRNE

Moderna (MRNA) Stock Moves -1.16%: What You Should Know

Abbott (ABT) Stock Moves -1.02%: What You Should Know

Pfizer sues for U.S. permission to assist patients needing expensive heart drugs

Inovio’s stock pulls back from 20-year high, even as longtime bull says it’s ‘less palatable’ after recent rally

Invitae's Market Opportunity Grows to $45 Billion After Latest Acquisition

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sorrento Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – SRNE

Inovio (INO) Stock Is a Winner, but Its Valuation Is Getting Stretched

Coronavirus Latest: Friday, June 26

Coronavirus update: Florida and Texas take steps back as US infections soar

U.S. to ship remdesivir to states including California and Texas with rising COVID-19 cases

These 6 health-care stocks are ‘buys’ because they can thrive under either Trump or Biden

Key U.S. medical group adds steroids to COVID-19 treatment guidelines

Here’s a hedge fund strategy that just might work for you

Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio

Inovio Stock Cut to Hold at Stifel on Valuation, Fundamentals

LAWSUITS FILED AGAINST SRNE, CCL and CSPR - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

Gilead's (GILD) Remdesivir Gets CHMP Approval Recommendation

Moderna Collaborates With Catalent for Coronavirus Vaccine

Infojet Club

With help but without the assistance of Yahoo Finance

Advertise With Us